Targeted fusion proteins for cancer therapy

Details for Australian Patent Application No. 2006314037 (hide)

Owner Dabur Pharma Limited

Inventors Nachiappan, Dhatchana Moorthy; Mukherjee, Rama; Maithal, Kapil

Agent Davies Collison Cave

Pub. Number AU-B-2006314037

PCT Pub. Number WO2007/057922

Priority 3084/DEL/2005 18.11.05 IN

Filing date 16 November 2006

Wipo publication date 24 May 2007

Acceptance publication date 23 September 2010

International Classifications

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

Event Publications

5 June 2008 PCT application entered the National Phase

  PCT publication WO2007/057922 Priority application(s): WO2007/057922

23 September 2010 Application Accepted

  Published as AU-B-2006314037

20 January 2011 Standard Patent Sealed

14 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006314048-A panel assembly

2006314025-Organic inorganic composite powder, process for producing the same and composition containing the powder